Effect of Gemfibrozil on Intermediate-Density Lipeproteins in NIDDM Patients: A Retrospective Study

Bell, David S H; Wagenknecht, Lynne E

doi:10.2337/diacare.15.1.146

Article navigation

Letters| January 01 1992

Effect of Gemfibrozil on Intermediate-Density Lipeproteins in NIDDM Patients: A Retrospective Study

David S H Bell, MD;

David S H Bell, MD

Division of Endocrinology and Metabolism and the School of Public Health of the University of Alabama at Birmingham

Birmingham, Alabama

Search for other works by this author on:

This Site

PubMed

Google Scholar

Lynne E Wagenknecht, DRPH

Division of Endocrinology and Metabolism and the School of Public Health of the University of Alabama at Birmingham

Birmingham, Alabama

Search for other works by this author on:

This Site

PubMed

Google Scholar

Address Correspondence and Reprint Requests to David S.H. Bell, MD, the University of Alabama at Birmingham, 1808 7th Avenue South, University Station, Birmingham, AL 35294.

Diabetes Care 1992;15(1):146–147

https://doi.org/10.2337/diacare.15.1.146

PubMed:

1737536

Effect of Gemfibrozil on Intermediate-Density Lipeproteins in NIDDM Patients: A Retrospective Study

Article PDF first page preview

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

Effect of Gemfibrozil on Intermediate-Density Lipeproteins in NIDDM Patients: A Retrospective Study

Article PDF first page preview

Email alerts

Journals

Books

Clinical Compendia

News

Podcasts

Other

About

Resources

This Feature Is Available To Subscribers Only